Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05098392 · ClinicalTrials.gov registry record · NA

Sibling-Mediated Intervention on Literacy and Reciprocity for Children With Autism

A NA study, sponsored by Arizona State University.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT05098392: Clinical Trial NA study, sponsored by Arizona State University.

NCT05098392 is a NA study that was terminated before completion, run by Arizona State University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05098392, a NA study, was terminated before completion, sponsored by Arizona State University.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

Given the increasing prevalence of autism spectrum disorder (ASD), estimated to be 1 in 68 in the United States alone, ASD has become one of the fastest-growing pediatric concerns. The deficits of children with ASD range across social communication and academic skills. One of the effective interventions that have been used commonly for ASD is the model-lead-test, which includes modeling, prompting children to practice target skills together, and providing children with affirmative feedback or error correction. Previous research has demonstrated that the model-lead-test is successful in teaching different skills for individuals with ASD, including functional, social, and academic skills. The vast majority of the studies had researchers, therapists, or teachers implement the intervention. However, there is clear empirical support and implications for interventions mediated by more familiar persons, such as parents and siblings, which may lead to better effects, maintenance, and generalization due to more practice opportunities in the natural environments. Research has supported the effectiveness of using parents or peers as agents to deliver interventions for individuals with ASD, whereas fewer studies explored the use of siblings to deliver or mediate intervention. As typically developing siblings are an essential part of the daily life of children with ASD, it makes logical extensions to have siblings as mediators to deliver interventions. In the initial findings, the investigators found the typically developing siblings can accurately implement the model-lead-test procedure that improved various skills of their siblings with ASD. This project will extend these findings by examining the efficacy of the sibling-implemented intervention on early literacy (reading) and social reciprocity (conversation and play) of children with ASD as well as the sibling relationship before, during, and after the intervention.

Primary Outcome

Participants in the US will complete DIBELS Grades K-1 Benchmark. Participants in China read pinyin's using a pinyin matrix

Interventions

  • BEHAVIORAL Sibling-mediated intervention

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2021-11-02
Est. Completion 2025-09-07
Phase NA
Arizona State University

187 total trials

Why NCT05098392 stopped before completion

NCT05098392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Sibling-mediated intervention is the first listed.

NCT05098392 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05098392 about?

NCT05098392 is a clinical study titled "Sibling-Mediated Intervention on Literacy and Reciprocity for Children With Autism". Given the increasing prevalence of autism spectrum disorder (ASD), estimated to be 1 in 68 in the United States alone, ASD has become one of the fastest-growing pediatric concerns. The deficits of children with ASD range across social communication and academic skills. One of the effective intervent...

What is the current status of trial NCT05098392?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2021-11-02. Estimated completion is 2025-09-07.

What interventions are being tested in trial NCT05098392?

The interventions under investigation include: Sibling-mediated intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05098392?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05098392's enrollment target sits among peer trials

8 1976th of 2000 higher than 19 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05098392, the US trial registry maintained by the National Library of Medicine. NCT05098392 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.